Editorial commentary: COVID-19 as a cardiovascular disease risk factor
- 16 July 2022
- journal article
- editorial
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 32 (8) , 476-478
Abstract
No abstract availableKeywords
Funding Information
- Merck
- Novartis
- National Institutes of Health
- Bristol Myers Squibb Foundation
This publication has 15 references indexed in Scilit:
- Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focusEuropean Heart Journal, 2022
- The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac InjuryJACC: Basic To Translational Science, 2022
- The Microbiome in Respiratory Disease2022
- Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 PandemicJAMA Psychiatry, 2021
- Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare WorkersJACC: Cardiovascular Imaging, 2021
- Cardiovascular Magnetic Resonance for Patients With COVID-19JACC: Cardiovascular Imaging, 2021
- Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a differenceTrends in Cardiovascular Medicine, 2021
- Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)Cardiovascular Research, 2021
- Sex differences in activity and health changes following COVID-19 in Europe—results from the SHARE COVID-19 surveyEuropean Journal of Public Health, 2021
- SARS-CoV-2 Cardiac Involvement in Young Competitive AthletesCirculation, 2021